Mindblown: a blog about philosophy.
-
Cal-Maine Foods Q3 FY26: A Solid Quarter That Still Needs to Prove Itself
Cal-Maine offers a solid business at a reasonable price. Just don’t expect the market to reward it quickly.
-
Why Copper Stocks Could Be the Hottest Trade of the Next Decade
Copper isn’t just in another commodity cycle, that’s why copper stocks are one of the most compelling investment themes of the next decade.
-
Nike’s Comeback Plan Faces Harsh Reality – Why It’s Best to Avoid
Nike has long-term potential, but its turnaround plan is clouded by slowing growth and weakening performance in key markets.
-
Conagra Stock: Cheap for a Reason, But Capitulation May Be Near
Conagra has mid-tier consumer brands that are caught between a pressured middle class and a company still digesting expensive acquisitions,
-
3 Travel Stocks to Buy and Hold as the Weather Warms Up
Expected seasonal demand is an opportunity to buy beaten-down travel stocks with strong fundamentals and clear catalysts for upside.
-
Five Safe Ways to Trade Cooling Volatility
In a cooling volatility environment investors can look toward ETFs that benefit from a more stable market environment.
-
McCormick Stock Dips on Unilever Merger—But Is the Sell-Off Overdone?
Value investors with a two- to three-year horizon should watch to see whether the combined McCormick can deliver on what its new scale implies.
-
3 Top Dividend ETFs to Hold for 10 Years
Dividend ETFs are attractive for investors who want consistent income while staying invested in equities that can compound over time.
-
Insider Buying Stocks: 3 Names to Watch on Pullbacks
One of the best ways to spot an opportunity is by tracking insider buying stocks, which often signals confidence in future growth.
-
3 Small Biotech Stocks With the Potential for Big Oncology Payoffs
Biotech stocks can deliver extraordinary gains when science and timing align, and the best time to accumulate shares is often when nobody else wants to look
Got any book recommendations?